Individuals may regard reproduction as optional but sufficient number of them must be productive to perpetuate the species. The reproductive system is surprisingly vulnerable and depends, among other things, on a limited endowment of oocytes, controlled proliferation of spermatogonial stem cells and the genetic integrity of both. The developmental competence of oocytes and spermatogonial stem cells is maintained by evolved mechanisms for cellular detoxification and genomic stability, and excess or damaged cells are eliminated by apoptosis. Gonadal failure as a result of germ cell depletion can occur at any age, and from the effects of chemical cytotoxicity, disease and infection as well as genetic predisposition. Among extrinsic factors, alkylating agents and ionizing radiation are important causes of iatrogenic gonadal failure in young women and men. In animal models, there is evidence that hormonal manipulation, deletion of genes involved in apoptotic pathways and dietary manipulation can protect against natural and induced germ cell loss, but evidence in humans is absent or unclear. Assisted reproductive technologies (ARTs) provide an ensemble of strategies for preserving fertility in patients and commercially valuable or endangered species. Semen cryopreservation was the first technology for preserving male fertility, but this cannot serve prepubertal boys, for whom banking of testicular biopsies may provide a future option. In sterilized rodents, cryopreserved spermatogonial stem cells can recolonize seminiferous tubules and reinitiate spermatogenesis, and subcutaneous implantation of intact tubules can generate spermatozoa for fertilization in vitro by intracytoplasmic sperm injection. Transplantation of frozen-banked ovarian tissue is well-established for restoring cyclicity and fertility and is currently undergoing clinical evaluation for cancer patients. When restoration of natural fertility is unnecessary or reimplantation is unsafe, it is desirable to culture the germ cells from thawed tissue in vitro until they reach the stage at which they can be fertilized. Low temperature banking of immature germ cells is potentially very versatile, but storage of embryos and, to a lesser extent, mature oocytes is already practised in a number of species, including humans, and is likely to remain a mainstay for fertility preservation.
This theory no longer has much credibility and there is no doubt that germline, like somatic, cells are subject to maladaptive deterioration and ageing. Indeed, modern gerontological theory predicts that germ cells are vulnerable.
Senescence is an ineluctable consequence of the declining force of natural selection with age, because fewer offspring are born to parents in successively older age cohorts (Williams, 1957) . Natural selection does not eliminate deleterious genes if they are late-acting (especially after the menopause) and, if the genes have beneficial effects at younger ages, they may even be positively selected. This theory of antagonistic pleiotropy predicts trade-offs between benefits at young ages and costs later on. Kirkwood and Cremer (1982) contributed a physiological perspective, expressed as the 'disposable soma theory', which states that although it is theoretically possible to invest sufficiently in somatic maintenance and repair to fend off harmful age changes, natural selection may favour a balance that falls short of immortality and results in senescence (Fig. 1) . The limiting resources would take many forms and include energy and nutrition, DNA repair and replacement of defective proteins, and response to cellular stress. The positive correlation between resistance to physiological stressors and lifespan in a range of mammalian species is consistent with (but not proof of) the disposable soma theory (Kapahi et al., 1999) . The theory was proposed to account for somatic ageing, but it can also apply to germ cells. Indeed, similar age changes and protective mechanisms might be expected in both germ and somatic cells, even if the expression varies among specific cell types. In this review, the most salient aspects of biology and pathology relevant to long-term fecundity are considered.
Fertility preservation figures importantly among the technologies of reproduction (Box 1). One of the most marked examples is cryopreservation of gametes and embryos for patients undergoing sterilizing treatment with high-dose chemotherapy who need to protect their reproductive options or desire to avoid premature menopause. Demographically, the biggest factor is natural ageing, as increasing numbers of women are postponing having children until ages when fertility has declined. This trend is most advanced in northern Europe and, in the Dutch population, the peak age for child-bearing is now 30-36 years (Stephen, 1999) . Oocyte fertility is often so poor and IVF success rates so low after 40 years of age that recourse to donor eggs may be required, even though most women at this age still ovulate regularly. In the second half of this review, existing and prospective options offered by assisted reproductive technology for preserving female and male fertility are considered. Not only can these methods meet the needs of patients, but some also serve useful roles in experimental biology and for conserving endangered species and rare animal breeds, strains and transgenics.
In vivo preservation
Stem cell proliferation and differentiation Gametes develop from similar stem cell precursors of the germ line in both sexes, but from the first trimester of human pregnancy the developmental histories of the gametes of the two sexes diverge. In females, oogonial stem cells are no longer detectable by, or shortly after, birth, whereas self-renewing spermatogonial stem cells remain in testes throughout life and can propagate spermatozoa from puberty to old age. Natural selection might be expected to favour greater biological investment in the limited store of female germ cells by rigorous elimination of abnormal genotypes (Fig. 2) . A number of genes involved in chromosome pairing and recombination checkpoints have already been identified in primary oocytes. For example, the gene for ataxia telangiectasia is a gene encoding a protein kinase involved in DNA metabolism, the mutated form of which causes primary ovarian failure, although some oocytes may escape and degenerate later (Xu et al., 1996) . In addition, homozygous deletion of the DNA mismatch repair gene mlh1 causes infertility in males and females as a result of halting meiosis at the pachytene stage. In addition, chromosome rearrangements during meiosis in fetuses with 45,XO and Xautosome translocations are associated with a zygotenepachytene checkpoint arrest reminiscent of the effect of mutations of Dmcr (Speed, 1988; Yoshida et al., 1998) . However, screening mechanisms are neither fully efficient, judging by the incidence of chromosomal nondisjunction in oocytes, nor can they account for all germ cell wastage. In the human ovary, only 15% of the initial germ cell population of 6-7 ϫ 10 6 remains at birth, and this number has fallen to 2.5 ϫ 10 4 by 37 years of age. During the last 1-2 decades of reproductive life, the rate of follicle disappearance accelerates two-threefold until the ovary is virtually sterile at the time of menopause (Faddy et al., 1992) . Even a slight slowing of the rate of follicle loss may have a significant impact on the number of follicles present at mid-life, and hence postpone menopause. However, no dietary or hormonal manipulation is known to affect the rate of follicle attrition in humans, although hypophysectomy and dietary restriction have pronounced and independent effects in laboratory animals (Jones and Krohn, 1961; Nelson et al., 1985) . There is no convincing evidence that pharmacologically induced hypogonadotrophism can protect small follicles from natural attrition. In testes of older individuals, there is usually a decline in endocrine and spermatogenic function, although this is rarely complete even at advanced ages (Neaves et al., 1984) . The most effective action for preventing testicular age changes is probably the preservation of good overall health.
The list of genes on sex chromosomes and autosomes required to establish the germ cell population in fetal gonads is growing rapidly, and their deletion can lead to ovarian dysgenesis or, at least, premature ovarian failure (for example, TIAR, Gcd, c-kit, GATA-4, DAZLA, WT-1, SOX-9, Zfx, Dia, FMR1, Bmp-4, FOXL2) (for more details, see http://ovary.stanford.edu; http://germonline.igh.cnrs.fr). Polymorphisms may account for variable numbers of female germ cells, although there is large stochastic variation (Finch and Kirkwood, 2000) . In males, induced mutagenesis and spontaneous microdeletions have pinpointed Y-linked genes required for spermatogenesis, for example the AZFc region in humans, and a surprisingly large number of genes on the X chromosome is also required for spermatogenesis (Wang et al., 2001) . In oogenesis, the key role of genes on the X chromosome is known from the phenotype of Turner's syndrome (45,XO), a critical region being Xq13-q26.
During maturation, endocrine, paracrine and autocrine signals determine the rate and fate of germ cells. In the ovary, GDF-9 expression by oocytes is required for growth and differentiation beginning at early stages (Carabatsos et al., 1998) . Follicles do not progress to oestrogenic stages unless stimulated with FSH (Aittomaki, 1995) . Spermatogenesis can be arrested at any stage between spermatogonia and mature gametes as a result of either mutations acting cell-autonomously or of cellular interactions. A member of the TGF-β superfamily of secreted growth factors, glial cell line-derived neurotrophic factor (GDNF), is produced by Sertoli cells with a paracrine effect (Meng et al., 2000) . Overexpression of GDNF causes spermatogonia to accumulate, indicating that it serves as a brake on cell differentiation. It is plausible that the rate-limiting step in spermatogenesis is controlled by the somatic cells most necessary for germ cell development. Another example of an interaction is the production of kit-ligand (KL) in soluble and bound forms by Sertoli and granulosa cells and its binding to the receptor tyrosine kinase c-kit on the respective germ cells. When neutralizing anti-c-kit antibodies are injected into rodents, the spermatogonial death rate increases 4-15-fold, indicating that KL acts as an inhibitor of apoptosis (Packer et al., 1995) .
Most mutant phenotypes are expressed during meiosis in male germ cells, reflecting the complexity of the process and the importance of excluding genetic errors. The genes have a wide range of functions in, for example, DNA mismatch repair, cell cycle control, RNA binding, the synaptonemal complex and various signalling molecules and their mediators. The phenotypes resulting from the inactivation of the genes can involve structural defects, such as impaired chromosome condensation in the case of the ubiquitin-conjugating DNA repair enzyme, HR6B (Roest et al., 1996) . However, in other cases, for example the molecular chaperone, calmegin (Ikawa et al., 1997) , spermatozoa retain a normal morphology but are unable to bind to the oocyte.
Cellular maintenance repair and apoptosis
Germ cell multiplication and differentiation are necessary but not sufficient alone to assure fertility; quality control, protection from environmental damage and elimination of defective cells are also required. The sperm head is a highly condensed structure in which transcription and DNA repair are precluded, and only after syngamy and nuclear decondensation can repair enzymes in the ooplasm gain access to the DNA. Oocytes have an impressive ability to repair pronuclear DNA defects from recombination errors or extrinsic agents, such as UV light and chemical mutagens (Ashwood-Smith and Edwards, 1996) .
The mitochondrial genome is more vulnerable than nuclear genes. High energy electrons leaking from the electron transport chain generate locally high concentrations of hydrogen peroxide, superoxide radicals (O 2 -) and the highly toxic hydroxyl radical (OH•), which can damage mitochondrial proteins and DNA and affect Ca 2+ homeostasis and reduced glutathione. Oocytes express genes encoding a panel of antioxidant enzymes, for example, Cu-Zn-superoxide dismutase is notably abundant (El Mouatassim et al., 1999) . Dietary vitamin E supplements boost α-tocopherol in avian spermatozoa, reducing the risk of lipid peroxidation to vulnerable membranes (Surai et al., 1998) , and the relationship between nutrition and fertility has been studied intensively in farm animals. Observations in vitro of the effects of oxidants (diamide) and reducing agents indicate that free radical action is a basis for oocyte ageing. Vitamin E-and C-enriched diets also improved oocyte quality in older animals (Tarin et al., 1998) , but relatively scant attention has been paid to the benefits, if any, of dietary manipulation for human fertility after 35 years of age.
Glutathione is an important component of cellular protection with a special role in decondensing the male pronucleus after fertilization. Consequently, depletion of glutathione in oocytes impairs chromatin remodelling (Sutovsky and Schatten, 1997). Embryos of transgenic mice overexpressing glutathione synthetase have higher rates of development in culture and are more resistant to diamide toxicity than are embryos of wild-type mice (Rzucidlo and Brackett, 2000) . The fact that normal fertility can be improved indicates that it has not evolved optimally, but this conclusion need not be surprising if physiological adaptation has been traded-off against different functions.
Mammalian chromosomes have repeated DNA sequences at their ends -TTAGGG(n) -known as telomeres, which shorten by some 50-200 base pairs during every cell cycle. The so-called 'immortal' cell types, germ cells and tumour stem cells, are thought to gain genomic stability in part by expressing more telomerase, a ribonucleoprotein that replaces lost telomeres (Holt and Shay, 1999) . Telomerase is developmentally regulated, and is more abundant in spermatogonia and growing oocytes than at later stages of gametogenesis, and is virtually absent in mature gametes (Eisenhauer et al., 1997; Ravindranath et al., 1997) . Cleaving embryos express telomerase abundantly (Betts and King, 1999) and, although deletion of the gene does not precipitate infertility, its importance in preserving the integrity of the germ line and counteracting age changes is beyond doubt.
Most germ cells in the ovary are eliminated by programmed cell death either before or after birth by the process of follicle atresia. The fate of follicles is determined by the balance of opposing actions of survival factors (for example, FSH, oestrogen, insulin-like growth factor I, epidermal growth factor, fibroblast growth factor and interleukin 1β) versus apoptosis-inducing factors (for example, androgens, tumour necrosis factor α and interleukin 6), as well as intracellular mediators such as Fas ligand, Bcl-2, Bcl-x and Bax (Gosden and Spears, 1997) . Apoptosis is apparently an important mechanism controlling male germ cell development in spermatogenesis (Print and Loveland, 2000) . Extensive germ cell apoptosis occurs during the first wave of spermatogenesis after birth (Wang et al., 1998) , and adult male germ cells also undergo apoptosis (Henriksen and Parvinen, 1998) . In addition, apoptotic cell death in spermatogenesis is frequently observed after induced mutations in mice. For instance, HSP70-2 is a heat-shock protein specific to spermatocytes and when the gene is inactivated, spermatogenesis fails because of impaired meiosis and subsequent apoptosis (Dix et al., 1996) . A recent study shows that the prototype of HSP70-2, HSP70, prevents apoptosis by inhibiting apoptotic protease-acting factor 1 (APAF-1), the deletion of which also causes spermatogenic failure (Beere et al., 2000; Honarpour et al., 2000; Saleh et al., 2000) .
Apoptosis is so crucial in the developing mouse ovary, that the age-specific number of follicles can be manipulated genetically. When the death gene bax is deleted by homologous recombination, young ovaries contain about three times as many oocytes as normal controls, and the difference persists for up to 2 years (Perez et al., 1999) . However, the aged bax -/-animals were as infertile as controls because uterine function deteriorates early in mice. The size of the follicle store in the ovary is also increased by disruption of the gene for acid sphingomyelinase, and treatment of adult mice with sphingosine-1-phosphate can prevent follicle destruction by ionizing radiation (Morita et al., 2000) . These results indicate that small lipid molecule therapy might protect fertility in cancer patients at risk of iatrogenic sterilization.
The concept of pharmacological protection is not new, even if now it has a more sophisticated basis. Steroid contraceptives have been administered to women with the aim of reducing ovarian cytotoxicity, although the theoretical and empirical bases were never strong (Chapman and Sutcliffe, 1981) . Although the inhibition of dominant follicles by suppressing FSH with these steroids is highly effective, there is no evidence that either primordial follicle recruitment or sensitivity to cytotoxins are affected. Although convincing evidence of clinical benefit for either sex is still dubious (Waxman et al., 1987) , pituitary suppression using GnRH analogues in rats indicates that this strategy should not be written off, at least for protecting the testis (Ward et al., 1990) . The repopulation index of seminiferous tubules has been shown to be almost completely restored 10-20 weeks after administering 5 Gy of ionizing radiation and a GnRH antagonist to rats (Shetty et al., 2000) . As the antagonist suppressed intratesticular testosterone, and the beneficial effect was reversed by testosterone (which, in turn, was blocked by flutamide), it was inferred that high concentrations of male hormones inhibit the growth and differentiation of spermatogonia, some of which always survive this dose of radiation.
As the prospects of long-term survival and cure for young cancer patients continue to increase, protecting their fertility is receiving higher priority (Apperley and Reddy, 1995; Blumenfeld and Haim, 1997; Meirow, 1999) . Only a small proportion of patients need to have their fertility safeguarded but, until recently, only semen cryopreservation and ovarian transposition were available (Tulandi and AlTook, 1998) . If reliable pharmacological alternatives become available, the relative advantages and risks of these treatments versus cryopreservation for preserving genetic parenthood will need to be assessed. However, at present, ART provides wellestablished options with new opportunities.
Low temperature preservation
Although pharmacological strategies may eventually have wide applications, clinical implementation should be cautious because of the possible harm to the health of future children after the inhibition of apoptosis in germ cells exposed to mutagens. However, there is much reassuring data about the genetic safety of long-term cryopreservation of spermatozoa and embryos. There are potential hazards from viral contamination in storage dewars, which require attention through stringent quality control (Fountain et al., 1997) . Freeze-drying is unlikely to replace cryopreservation because, although lyophilized spermatozoa can fertilize oocytes, extensive molecular damage is probably incurred. Besides, low temperature preservation is versatile, proven effective and can be used for tissues, and perhaps eventually for whole organs in addition to germ cells and embryos (Fig. 3) . Semen (Lass et al., 1998) and embryos (Atkinson et al., 1994) are already banked routinely for cancer patients before they undergo potentially sterilizing chemotherapy or radiotherapy. Patients receiving sub-sterilizing doses are not normally offered this service even if they are treated with potentially mutagenic alkylating agents, because no evidence has yet been presented of excess birth defects among children of former cancer patients (Green et al., 1991). However, transgenerational effects of cyclophosphamide treatment have been reported in animals (Hales et al., 1992; Meirow et al., 2001) , and these disquieting data should serve as a warning and a stimulus for continued vigilance in research.
Male fertility
The first breakthrough in reproductive cryobiology over 50 years ago was the discovery that glycerol could preserve cockerel and bull spermatozoa during freezing and thawing. The pioneers, working at Mill Hill in London, quickly extended their efforts to other reproductive and nonreproductive tissues, but success rates varied with cell size, structure and membrane permeability. Some types of cell have proved very difficult to cryopreserve and success has only recently been achieved with mouse spermatozoa, Drosophila embryos and human oocytes, and protocols are still not optimal. In addition, semen cryopreservation is not automatically effective, partly for technical reasons but also because of specimen heterogeneity. In a retrospective survey of 231 young cancer patients, half of the men produced subfertile semen samples (< 10 7 motile spermatozoa per ejaculate), and 17% did not produce enough motile spermatozoa for frozen banking (Lass et al., 1998) . Sperm aspiration from the epididymis or testis for intracytoplasmic sperm injection (ICSI) can now provide a backup for cases of complete azoospermia in semen, although this is not always successful and new strategies must be sought for prepubertal boys.
The Brinster laboratory in Philadelphia first demonstrated that gonocytes from immature mouse testes can restore spermatogenesis after they are injected into the seminiferous tubules of adult hosts rendered sterile with busulphan or a mutation (Brinster and Avarbock, 1994) , and the technique succeeded with both fresh and cryopreserved cells (Avarbock et al., 1996) . Spermatogonial stem cells are rare in the germinal epithelium (10 -4 ), but there were enough in the cell suspensions for migration between Sertoli cells and recolonization of the basal compartment of the tubule to propagate fertile spermatozoa. By extension, spermatogonia can be transfected in vitro with DNA carried by a viral vector (Nagano et al., 2000) , but targeted genetic modification of the germ line is not yet feasible because it requires selection of the rare cells with homologous recombination. Moreover, the slow rate of stem cell multiplication is a limiting factor. However, germ cell transfer does offer scope for safeguarding the fertile potential of child patients when stem cells are returned via the rete testis or the vasa efferentia rather than the seminiferous tubules which are fibrous in humans (Schlatt et al., 1999; Brook et al., 2001) . If this technique proves to be only partially effective in patients without a full restoration of spermatogenesis, assisted reproduction will still be needed, and will detract from the main advantage of restoring natural fertility. Hence, autografts of seminiferous tubules from frozen-thawed testicular biopsies may be a more practicable strategy for prepubertal patients. Enough mature spermatozoa can probably be generated in a subcutaneous graft for an attempt at fertilization using ICSI (Gosden et al., 2000) .
Female fertility
Female fertility has the natural advantage of involving only one ovulation per month, compared with males who need to produce almost 10 8 spermatozoa each day, but the quality of the oocytes and embryos and their resistance to freeze-thawing is highly variable. Since it was first reported by Trounson and Mohr (1983) , human embryo banking has become a mainstay of ART, although it is used mainly with spare embryos to avoid repetition of an entire IVF cycles rather than for fertility preservation per se.
In principle, it is more desirable to store oocytes than embryos, but the technology has proved much more difficult in practice, at least in humans and in animal oocytes, which are sensitive to chilling and have delicate spindles and, in some cases (for example, cows and pigs) have a high lipid content. Apart from cryosurvival, a chief concern has been depolymerization of the metaphase spindle, which causes dispersion of chromosomes and production of potentially aneuploid conceptuses. After a short flurry of clinical reports in the mid-1980s, oocyte cryopreservation was voluntarily suspended. A decade later, pregnancies were reported again, and the better results were attributed to the use of propanediol as the cryoprotectant and ICSI for bypassing a hardened zona (Porcu et al., 1997) . Nevertheless, pregnancy rates remain below those obtained after embryo cryopreservation, and confidence will have to be raised before it is used widely as an insurance against premature ovarian failure or to preserve fertility after natural waning of ovarian function. There have also been experimental and clinical reports of ultra-rapid freezing (vitrification), which may avoid the problem of sensitivity to chilling injury, although the exceptionally high concentrations of cryoprotectants raise other concerns. Optimal cryopreservation requires a delicate balance to be made between preventing ice crystal formation and solute effects on the one hand and toxicity on the other; no protocol apparently can yet be considered to be optimal.
In addition, there is the possibility of preserving the thousands of immature follicles in ovarian tissue. These follicles might be used to generate embryos using ART or to restore fertility naturally by grafting, which provides the dividend of reversing hypo-oestrogenism and menopausal changes. British pioneers of cryobiology obtained some early successes in the 1950s by cooling ovarian tissue to -79ЊC in 15% glycerol and thawing it rapidly. Although the low permeability of glycerol makes it an unsatisfactory cryoprotectant, evidence of oestrogen secretion was obtained from isografts in rats (Parkes and Smith, 1952) and, in one trial in mice, fertility was restored after orthotopic ovarian grafting (Parrott, 1960) . Advances in cryotechnology now enable extension to the larger ovaries of farm animals and humans using autografts or xenografts in immunodeficient mice (Newton et al., 1996; Baird et al., 1999; Weissman et al., 1999) . These data have given impetus to bank cortical tissue for patients, and attempts are now being made to autotransplant the thawed tissue to restore cyclicity and perhaps fertility (Oktay and Karlikaya, 2000; Radford et al., 2001) . In laboratory and farm animals, isolated primordial follicles (Carroll and Gosden, 1993) and cortical tissue slices (Harp et al., 1994; Baird et al., 1999; Candy et al., 2000) have restored ovarian function and fertility after freezing, thawing and grafting. Heterotopic grafts are an alternative to the orthotopic site, although they require the recovery of oocytes for IVF if they are to serve as more than a hormonal graft (Leporrier et al., 1987; Aubard et al., 1999) . The possibility of using these techniques for children is a major incentive (Grundy et al., 2001) , although transplantation may be ruled out where there is a risk of disease becoming recrudescent from gonadal tissue (Kim et al., 2001) .
It is too early to predict how far this technology will serve the purposes of fertility preservation or the direction of the next phase of development. Research needs to address the safety and efficiency of tissue preservation, and may eventually enable the banking of whole organs for transplantation with vascular reanastomosis. Tissue cryopreservation has not proved to be as problematic as expected, but many follicles are lost by ischaemia after grafting (Nugent et al., 1998) .
Perhaps all of these problems will be overcome eventually by growing oocytes to maturity in vitro. Realisation of that goal will then have implications beyond fertility preservation. The technology required to reach this goal is far more demanding than that required for the routine development of zygotes to the blastocyst stage. Oocyte growth and differentiation are much more protracted and require stage-specific conditions and signals from both the external medium and cumulus-granulosa cells. The production entirely in vitro of mature oocytes from primordial follicles has only been achieved once, and occurred in a rodent species (Eppig and O'Brien, 1996) . Progress is being made stepwise with different follicle stages, but some success has already been recorded after cryopreservation (Cortvrindt et al., 1996; Newton et al., 1999) as well as with farm animal and human follicles (Abir et al., 1997; Gutierrez et al., 2000) . When oocytes have reached full size and are meiotically competent, nuclear maturation followed by IVF in vitro can be achieved with an efficiency that is already high enough for clinical practice (Chian et al., 2000) . Although research will first have to prove that extended culture does not induce epigenetic defects (Doherty et al., 2000) , full development of female and male germ cells in vitro will contribute to the ongoing revolution in reproductive technology. Such progress will certainly provide new and welcome options for fertility conservation.
